August 17, 2026

Exelixis, Inc. (EXEL) Stock Analysis: Evaluating the 3.31% Upside with Strong Revenue Growth

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology industry, continues to make strides in the healthcare sector with its innovative oncology treatments. With a market capitalization of $12.7..

Zoetis Inc. (ZTS) Stock Analysis: Potential 36.79% Upside Amid Healthcare Sector Dynamics

Zoetis Inc. (NYSE: ZTS), a leading player in the healthcare sector specializing in animal health solutions, presents a unique investment opportunity. With a market capitalization of $30.49 billion, Zoetis is..

Baxter International Inc. (BAX) Stock Analysis: Evaluating Growth Potential with Insightful Valuation Metrics

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, is a company with a rich history dating back to its incorporation in 1931. Headquartered in Deerfield, Illinois, Baxter..

Telix Pharmaceuticals Limited (TLX): Analyst Ratings Signal an 80% Upside Potential for this Biotech Stock

Telix Pharmaceuticals Limited (ASX: TLX), an Australian-based biopharmaceutical company, is making waves in the healthcare sector with its promising pipeline of radiopharmaceuticals. As a commercial-stage company, Telix focuses on the..

Regeneron Pharmaceuticals (REGN): Investor Outlook with Strong Buy Consensus and Notable Growth Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands as a formidable player in the biotechnology sector with a market capitalization of $82.72 billion. The company has consistently demonstrated its prowess in developing..

Johnson & Johnson (JNJ)

⚠️ No article content returned.

..

West Pharmaceutical Services (WST): Analyst Consensus and 15.83% Potential Upside

West Pharmaceutical Services, Inc. (WST), a key player in the healthcare sector with a focus on medical instruments and supplies, has been capturing investor attention with its solid market presence..

Merck & Company, Inc. (MRK) Investor Outlook: Exploring Growth with a Robust Pipeline and Strategic Collaborations

Merck & Company, Inc. (NYSE: MRK), a titan in the healthcare sector, continues to intrigue investors with its strategic collaborations and a broad portfolio of pharmaceutical products. As a major..

Royalty Pharma plc (RPRX) Stock Analysis: Unpacking a 10.49% Potential Upside

For investors seeking exposure to the dynamic biopharmaceutical space, Royalty Pharma plc (NASDAQ: RPRX) presents a compelling proposition. Specializing in the acquisition of biopharmaceutical royalties, Royalty Pharma stands out with..

The Cooper Companies, Inc. (COO)

⚠️ No article content returned.

..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring a 33.87% Potential Upside in the Healthcare Sector

Waystar Holding Corp. (NASDAQ: WAY), a rising star in the healthcare sector, is capturing the attention of investors with its robust potential upside of 33.87%, according to recent analyst ratings...

Stevanato Group S.p.A. (STVN) Stock Analysis: A Solid Healthcare Play with a 17.46% Upside Potential

Stevanato Group S.p.A. (NYSE: STVN) has captured the attention of investors with its promising position in the healthcare sector, particularly in the Medical Instruments & Supplies industry. Headquartered in Piombino..

Danaher Corporation (DHR) Stock Analysis: Healthcare Powerhouse with 12.60% Potential Upside

Danaher Corporation (NYSE: DHR), a prominent player in the healthcare sector, is drawing the attention of discerning investors with its robust market presence and promising growth prospects. With a market..

Vaxcyte, Inc. (PCVX) Stock Analysis: Unraveling the 87.70% Potential Upside

Investors eyeing the biotechnology sector should take a closer look at Vaxcyte, Inc. (NASDAQ: PCVX), a clinical-stage vaccine innovation company with an ambitious pipeline of vaccine candidates targeting bacterial infectious..

Align Technology, Inc. (ALGN) Stock Analysis: Unveiling a 15% Potential Upside in the Dynamic Medical Instruments Sector

Align Technology, Inc. (NASDAQ: ALGN), a key player in the healthcare sector, specifically within the medical instruments and supplies industry, presents a compelling case for investors eyeing the healthcare market...

Elevance Health, Inc. (ELV) Stock Analysis: Exploring the 12.18% Potential Upside

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans sector, is capturing the attention of investors with its promising potential upside of 12.18%. With a robust market..

Doximity, Inc. (DOCS) Stock Analysis: Navigating a 17.38% Potential Upside Amidst Health Information Services Growth

Doximity, Inc. (NYSE: DOCS), a prominent player in the health information services sector, is catching the eye of investors with its digital platform tailored for medical professionals. Currently positioned with..

Bio-Techne Corp (TECH) Stock Analysis: Navigating the Biotech Giant’s Modest Growth and Analyst Consensus

Bio-Techne Corp (NASDAQ: TECH) stands as a prominent player in the biotechnology sector, with a market capitalization of $11.28 billion. Based in Minneapolis, Minnesota, the company is known for its..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Powerhouse with 6.21% Potential Upside

Lantheus Holdings, Inc. (NASDAQ: LNTH) stands as a significant player in the healthcare sector, specifically within the realm of specialty and generic drug manufacturing. With a market capitalization of $6.59..

Alkermes plc (ALKS) Stock Analysis: A Look at the 14.15% Potential Upside

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector, is making waves in the biopharmaceutical industry with a robust portfolio that addresses unmet medical needs across various therapeutic..

Search

Funds

August 17, 2026

Search

Funds

August 17, 2026

FTSE 100

Funds